Ibrexafungerp is a first-in-class, orally active triterpenoid antifungal agent. It is structurally distinct from azoles and echinocandins and was developed specifically to overcome resistance and tolerability issues seen with older antifungals. Its therapeutic use is listed as anti-infectives and antifungals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include ibrexafungerpum, pyridin-4-yl-1, 2, 4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01, 14.02, 11.05 and 10)henicos-2-ene-6-carboxylic acid. Its PubChem CID is 46871657.
Ibrexafungerp
| CAS No | 1207753-03-4 |
|---|---|
| Molecular Formula | C44H67N5O4 |
| Molecular Weight | 730.0 g/mol |
| Synonyms | (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ibrexafungerp is a first-in-class, orally active triterpenoid antifungal agent. It is structurally distinct from azoles and echinocandins and was developed specifically to overcome resistance and tolerability issues seen with older antifungals.
The listed CAS number is 1207753-03-4.
The listed molecular formula is C44H67N5O4.
The listed molecular weight is 730.0 g/mol.
(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid.
The source lists ibrexafungerpum, pyridin-4-yl-1, 2, 4-triazol-1-yl)-17-oxapentacyclo(13.3.3.01, 14.02, 11.05 and 10)henicos-2-ene-6-carboxylic acid.